Medistim ASA reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was NOK 124.1 million compared to NOK 116.49 million a year ago. Net income was NOK 26.13 million compared to NOK 24.65 million a year ago. Basic earnings per share from continuing operations was NOK 1.43 compared to NOK 1.35 a year ago. Diluted earnings per share from continuing operations was NOK 1.43 compared to NOK 1.35 a year ago.
For the nine months, sales was NOK 390.75 million compared to NOK 350.11 million a year ago. Net income was NOK 84.71 million compared to NOK 81.5 million a year ago. Basic earnings per share from continuing operations was NOK 4.64 compared to NOK 4.47 a year ago. Diluted earnings per share from continuing operations was NOK 4.63 compared to NOK 4.46 a year ago.